IP Library › Granted Patent US 6,566,341
Granted Patent Utility
US 6,566,341 · Confirmation No. 1428

DERIVATIVE OF ISOINDIGO, INDIGO AND INDIRUBIN FOR THE TREATMENT OF CANCER

Patented Case View Patent ↗
⬇ PDF
 Code Description Pages PDF
2014-08-21 SES.LOSS Notification of loss of entitlement to small entity status 1 View
2014-08-21 N417 Electronic Filing System Acknowledgment Receipt 2 View
2012-02-29 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2012-02-29 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2012-02-17 PA.. Power of Attorney 2 View
2012-02-17 N417 Electronic Filing System Acknowledgment Receipt 2 View
2012-02-17 R3.73 Assignee showing of ownership per 37 CFR 3.73 2 View
2001-12-13 TRNA Transmittal of New Application 2 View
2001-12-13 SPEC Specification 24 View
2001-12-13 CLM Claims 6 View
2001-12-13 ABST Abstract 1 View
2001-12-13 DRW Drawings-only black and white line drawings 7 View
2001-12-13 OATH Oath or Declaration filed 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
Patent No.
US 6,566,341
App. No.
10/021,589
Filed
2001-12-13
Granted
2003-05-20
Art Unit
1623
PTA
-113 days